RONALD O PERELMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RONALD O PERELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RONALD O PERELMAN. RONALD O PERELMAN is in SCIENTIFIC GAMES CORP ($SGMS) and 10% Owner in SCIENTIFIC GAMES CORP ($SGMS) and Director in SCIENTIFIC GAMES CORP ($SGMS) and Executive Chairman in SCIENTIFIC GAMES CORP ($SGMS) and Director in M & F WORLDWIDE CORP ($MFW) and Director in REVLON INC /DE/ ($REV) and Director in PANAVISION INC ($PVIS.OB) and 10% Owner in SIGA TECHNOLOGIES INC ($SIGA) and in vTv Therapeutics Inc. ($VTVT) and 10% Owner in vTv Therapeutics Inc. ($VTVT).
Latest Insider Trading Transactions of RONALD O PERELMAN
Sentiment: All, MFW, PVIS.OB, REV, SGMS, SIGA, VTVT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 12 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 24.39 | 10,177 | 248,242 | 45,098,321 | 45.1 M to 45.1 M (+0.02 %) |
Dec 12 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 24.42 | 11,014 | 268,929 | 45,088,144 | 45.1 M to 45.1 M (+0.02 %) |
Dec 12 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | J | 2.12 | 1 | 2 | 1 | ||
Dec 12 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | J | 1.84 | 1 | 2 | 1 | ||
Dec 10 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 24.24 | 43,770 | 1,060,937 | 45,077,130 | 45 M to 45.1 M (+0.10 %) |
Dec 10 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 24.23 | 25,335 | 613,915 | 45,033,360 | 45 M to 45 M (+0.06 %) |
Dec 10 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 23.27 | 5,895 | 137,180 | 45,008,025 | 45 M to 45 M (+0.01 %) |
Nov 30 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | O | 1.33 | 1 | 1 | 0 | ||
Nov 30 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 1.33 | 1,879,700 | 2,500,001 | 12,417,568 | 10.5 M to 12.4 M (+17.84 %) | |
Nov 07 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | O | 1.33 | 1 | 1 | 1 | ||
Nov 07 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 1.33 | 1,879,699 | 2,500,000 | 10,537,868 | 8.7 M to 10.5 M (+21.71 %) | |
Oct 01 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | O | 1.33 | 1 | 1 | 1 | ||
Oct 01 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 1.33 | 1,879,699 | 2,500,000 | 8,658,169 | 6.8 M to 8.7 M (+27.73 %) | |
Sep 25 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 21.50 | 35,000 | 752,374 | 45,002,130 | 45 M to 45 M (+0.08 %) |
Sep 24 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 21.29 | 50,220 | 1,069,214 | 44,967,130 | 44.9 M to 45 M (+0.11 %) |
Sep 24 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 20.60 | 49,780 | 1,025,573 | 44,916,910 | 44.9 M to 44.9 M (+0.11 %) |
Sep 13 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 20.88 | 20,000 | 417,662 | 44,867,130 | 44.8 M to 44.9 M (+0.04 %) |
Sep 10 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | O | 1.33 | 1 | 1 | 1 | ||
Sep 10 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 1.33 | 1,879,699 | 2,500,000 | 6,778,470 | 4.9 M to 6.8 M (+38.37 %) | |
Aug 20 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.45 | 10,000 | 174,488 | 44,847,130 | 44.8 M to 44.8 M (+0.02 %) |
Aug 20 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.49 | 10,000 | 174,903 | 44,837,130 | 44.8 M to 44.8 M (+0.02 %) |
Aug 16 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.52 | 20,000 | 350,398 | 44,827,130 | 44.8 M to 44.8 M (+0.04 %) |
Aug 16 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.80 | 20,000 | 356,022 | 44,807,130 | 44.8 M to 44.8 M (+0.04 %) |
Aug 14 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.49 | 25,000 | 437,210 | 44,787,130 | 44.8 M to 44.8 M (+0.06 %) |
Aug 14 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.20 | 50,000 | 860,035 | 44,762,130 | 44.7 M to 44.8 M (+0.11 %) |
Aug 14 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.49 | 25,000 | 437,210 | 44,787,130 | 44.8 M to 44.8 M (+0.06 %) |
Aug 14 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.20 | 50,000 | 860,035 | 44,762,130 | 44.7 M to 44.8 M (+0.11 %) |
Aug 14 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | O | 4.38 | 1 | 4 | 0 | ||
Aug 14 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.38 | 570,777 | 2,500,003 | 4,898,771 | 4.3 M to 4.9 M (+13.19 %) | |
Aug 13 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Buy | P | 31.95 | 72,924 | 2,329,922 | 34,750,736 | 34.7 M to 34.8 M (+0.21 %) | |
Aug 13 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Buy | P | 31.95 | 72,924 | 2,329,922 | 34,750,736 | 34.7 M to 34.8 M (+0.21 %) | |
Aug 13 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Buy | P | 31.57 | 102,076 | 3,222,539 | 34,677,812 | 34.6 M to 34.7 M (+0.30 %) | |
Aug 13 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Buy | P | 31.57 | 102,076 | 3,222,539 | 34,677,812 | 34.6 M to 34.7 M (+0.30 %) | |
Aug 13 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.05 | 51,097 | 871,005 | 44,712,130 | 44.7 M to 44.7 M (+0.11 %) |
Aug 13 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 16.33 | 23,903 | 390,293 | 44,661,033 | 44.6 M to 44.7 M (+0.05 %) |
Aug 13 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 15.88 | 53,825 | 854,822 | 44,637,130 | 44.6 M to 44.6 M (+0.12 %) |
Aug 13 2018 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 15.18 | 10,118 | 153,543 | 44,583,305 | 44.6 M to 44.6 M (+0.02 %) |
Aug 01 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | J | 1.53 | 1 | 2 | 1 | ||
Aug 01 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | J | 1.33 | 1 | 1 | 1 | ||
Jul 10 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | O | 4.38 | 1 | 4 | 1 | ||
Jul 10 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.38 | 570,776 | 2,499,999 | 4,327,994 | 3.8 M to 4.3 M (+15.19 %) | |
Jun 21 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 1,554 | 0 | 4,665 | |
Jun 21 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 1,554 | 0 | 4,665 | |
Jun 21 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 1,554 | 0 | 88,032 | 86.5 K to 88 K (+1.80 %) |
Jun 21 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 1,554 | 0 | 88,032 | 86.5 K to 88 K (+1.80 %) |
Jun 20 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | O | 4.38 | 1 | 4 | 1 | ||
Jun 20 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.38 | 570,776 | 2,499,999 | 3,757,218 | 3.2 M to 3.8 M (+17.91 %) | |
Jun 15 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 4,338 | 0 | 8,677 | |
Jun 15 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | A | 0.00 | 2,787 | 0 | 2,787 | |
Jun 15 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 4,338 | 0 | 86,478 | 82.1 K to 86.5 K (+5.28 %) |
Jun 12 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 3,495 | 0 | 0 | |
Jun 12 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 2,484 | 0 | 2,485 | |
Jun 12 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 3,495 | 0 | 82,140 | 78.6 K to 82.1 K (+4.44 %) |
Jun 12 2018 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 2,484 | 0 | 78,645 | 76.2 K to 78.6 K (+3.26 %) |
May 29 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | O | 4.38 | 1 | 4 | 1 | ||
May 29 2018 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.38 | 570,776 | 2,499,999 | 3,186,442 | 2.6 M to 3.2 M (+21.82 %) | |
Dec 27 2017 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.03 | 50,000 | 201,720 | 2,615,666 | 2.6 M to 2.6 M (+1.95 %) | |
Dec 07 2017 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | J | 5.04 | 1 | 5 | 1 | ||
Dec 07 2017 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | J | 4.38 | 1 | 4 | 1 | ||
Nov 06 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 22.43 | 47,355 | 1,062,059 | 44,573,187 | 44.5 M to 44.6 M (+0.11 %) |
Nov 06 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Sell | J | 0.00 | 15,258 | 0 | 44,525,832 | 44.5 M to 44.5 M (-0.03 %) |
Sep 27 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 21.45 | 40,100 | 860,069 | 44,541,090 | 44.5 M to 44.5 M (+0.09 %) |
Sep 27 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 20.03 | 66,684 | 1,335,761 | 44,500,990 | 44.4 M to 44.5 M (+0.15 %) |
Sep 21 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 18.11 | 175,993 | 3,187,814 | 44,434,306 | 44.3 M to 44.4 M (+0.40 %) |
Sep 21 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.75 | 159,383 | 2,829,781 | 44,258,313 | 44.1 M to 44.3 M (+0.36 %) |
Sep 21 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 16.80 | 252,645 | 4,243,173 | 44,098,930 | 43.8 M to 44.1 M (+0.58 %) |
Sep 21 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 15.95 | 37,130 | 592,253 | 43,846,285 | 43.8 M to 43.8 M (+0.08 %) |
Aug 24 2017 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.57 | 20,000 | 91,324 | 2,565,666 | 2.5 M to 2.6 M (+0.79 %) | |
Aug 16 2017 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.97 | 10,000 | 49,678 | 2,545,666 | 2.5 M to 2.5 M (+0.39 %) | |
Aug 15 2017 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.88 | 15,000 | 73,229 | 2,535,666 | 2.5 M to 2.5 M (+0.60 %) | |
Aug 15 2017 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.65 | 35,000 | 162,736 | 2,520,666 | 2.5 M to 2.5 M (+1.41 %) | |
Aug 11 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 18.62 | 80,568 | 1,500,096 | 43,809,155 | 43.7 M to 43.8 M (+0.18 %) |
Aug 11 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 18.75 | 171,474 | 3,214,657 | 43,728,587 | 43.6 M to 43.7 M (+0.39 %) |
Aug 11 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 18.25 | 28,526 | 520,651 | 43,557,113 | 43.5 M to 43.6 M (+0.07 %) |
Aug 09 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 19.00 | 298,200 | 5,665,323 | 43,528,587 | 43.2 M to 43.5 M (+0.69 %) |
Aug 09 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 18.43 | 1,800 | 33,168 | 43,230,387 | 43.2 M to 43.2 M (0.00 %) |
Aug 09 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 18.44 | 3,449 | 63,592 | 43,228,587 | 43.2 M to 43.2 M (+0.01 %) |
Aug 09 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 17.92 | 61,483 | 1,101,917 | 43,225,138 | 43.2 M to 43.2 M (+0.14 %) |
Aug 09 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 16.82 | 54,195 | 911,620 | 43,163,655 | 43.1 M to 43.2 M (+0.13 %) |
Jun 23 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 23.00 | 51,784 | 1,190,954 | 43,109,460 | 43.1 M to 43.1 M (+0.12 %) |
Jun 23 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 23.17 | 98,426 | 2,281,013 | 43,057,676 | 43 M to 43.1 M (+0.23 %) |
Jun 21 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 22.97 | 135,063 | 3,101,884 | 42,959,250 | 42.8 M to 43 M (+0.32 %) |
Jun 21 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 22.91 | 120,618 | 2,762,948 | 42,824,187 | 42.7 M to 42.8 M (+0.28 %) |
Jun 21 2017 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | A | 0.00 | 6,219 | 0 | 6,219 | |
Jun 19 2017 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 4,338 | 0 | 13,015 | |
Jun 19 2017 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 4,338 | 0 | 76,161 | 71.8 K to 76.2 K (+6.04 %) |
Jun 16 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 21.78 | 56,392 | 1,228,133 | 42,703,569 | 42.6 M to 42.7 M (+0.13 %) |
Jun 16 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 21.94 | 78,502 | 1,722,397 | 42,647,177 | 42.6 M to 42.6 M (+0.18 %) |
Jun 16 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 21.28 | 57,007 | 1,213,155 | 42,568,675 | 42.5 M to 42.6 M (+0.13 %) |
Jun 16 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 20.94 | 100,000 | 2,093,700 | 42,511,668 | 42.4 M to 42.5 M (+0.24 %) |
Jun 13 2017 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 3,495 | 0 | 3,495 | |
Jun 13 2017 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 2,484 | 0 | 4,969 | |
Jun 13 2017 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 3,495 | 0 | 71,823 | 68.3 K to 71.8 K (+5.12 %) |
Jun 13 2017 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 2,484 | 0 | 68,328 | 65.8 K to 68.3 K (+3.77 %) |
Jun 12 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 20.16 | 50,000 | 1,008,235 | 42,411,668 | 42.4 M to 42.4 M (+0.12 %) |
Jun 12 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 20.30 | 95,987 | 1,948,162 | 42,361,668 | 42.3 M to 42.4 M (+0.23 %) |
Jun 12 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 19.21 | 101,041 | 1,940,826 | 42,265,681 | 42.2 M to 42.3 M (+0.24 %) |
Jun 12 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 19.01 | 100,000 | 1,900,870 | 42,164,640 | 42.1 M to 42.2 M (+0.24 %) |
Jun 06 2017 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 1,725 | 0 | 0 | |
Jun 06 2017 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 1,725 | 0 | 65,844 | 64.1 K to 65.8 K (+2.69 %) |
May 31 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 18.61 | 70,000 | 1,302,553 | 42,064,640 | 42 M to 42.1 M (+0.17 %) |
May 31 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 18.73 | 50,000 | 936,515 | 41,994,640 | 41.9 M to 42 M (+0.12 %) |
May 19 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 19.31 | 125,000 | 2,413,125 | 41,944,640 | 41.8 M to 41.9 M (+0.30 %) |
May 19 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 19.48 | 100,000 | 1,948,450 | 41,819,640 | 41.7 M to 41.8 M (+0.24 %) |
May 15 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 20.00 | 100,000 | 2,000,000 | 41,719,640 | 41.6 M to 41.7 M (+0.24 %) |
May 09 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 20.47 | 200,000 | 4,093,260 | 41,619,640 | 41.4 M to 41.6 M (+0.48 %) |
May 09 2017 | REV | REVLON INC /DE/ | PERELMAN RONALD O | Director | Buy | P | 20.39 | 750,000 | 15,290,925 | 41,419,640 | 40.7 M to 41.4 M (+1.84 %) |
Jun 17 2016 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | A | 0.00 | 17,353 | 0 | 17,353 | |
Jun 14 2016 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 3,495 | 0 | 6,990 | |
Jun 14 2016 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 2,484 | 0 | 7,453 | |
Jun 14 2016 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 3,495 | 0 | 64,119 | 60.6 K to 64.1 K (+5.77 %) |
Jun 14 2016 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 2,484 | 0 | 60,624 | 58.1 K to 60.6 K (+4.27 %) |
Jun 07 2016 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 2,371 | 0 | 0 | |
Jun 07 2016 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 1,725 | 0 | 1,725 | |
Jun 07 2016 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 2,371 | 0 | 58,140 | 55.8 K to 58.1 K (+4.25 %) |
Jun 07 2016 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 1,725 | 0 | 55,769 | 54 K to 55.8 K (+3.19 %) |
Apr 05 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 5.20 | 100,000 | 519,960 | 2,390,666 | 2.3 M to 2.4 M (+4.37 %) | |
Apr 05 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 5.20 | 300,000 | 1,560,000 | 2,290,666 | 2 M to 2.3 M (+15.07 %) | |
Mar 28 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 5.64 | 10,000 | 56,438 | 1,990,666 | 2 M to 2 M (+0.50 %) | |
Mar 18 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Option Exercise | J | 0.00 | 25,035 | 0 | 23,084,267 | ||
Feb 16 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 5.83 | 10,000 | 58,250 | 1,980,666 | 2 M to 2 M (+0.51 %) | |
Feb 05 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.43 | 10,000 | 64,257 | 1,970,666 | 2 M to 2 M (+0.51 %) |
Feb 04 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.05 | 20,000 | 121,030 | 1,960,666 | 1.9 M to 2 M (+1.03 %) |
Apr 11 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | Buy | P | 4.99 | 10,000 | 49,906 | 2,400,666 | 2.4 M to 2.4 M (+0.42 %) | |
Jan 20 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.58 | 10,000 | 65,791 | 1,940,666 | 1.9 M to 1.9 M (+0.52 %) |
Jan 14 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.43 | 10,000 | 64,253 | 1,930,666 | 1.9 M to 1.9 M (+0.52 %) |
Jan 14 2016 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.39 | 5,000 | 31,934 | 1,920,666 | 1.9 M to 1.9 M (+0.26 %) |
Dec 21 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.40 | 15,000 | 96,057 | 1,915,666 | 1.9 M to 1.9 M (+0.79 %) |
Nov 24 2015 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | P | 8.55 | 10,000 | 85,521 | 34,575,737 | 34.6 M to 34.6 M (+0.03 %) |
Nov 24 2015 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | P | 8.28 | 10,000 | 82,755 | 34,565,737 | 34.6 M to 34.6 M (+0.03 %) |
Nov 18 2015 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | P | 7.80 | 50,000 | 390,075 | 34,555,737 | 34.5 M to 34.6 M (+0.14 %) |
Nov 18 2015 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | P | 8.15 | 90,000 | 733,176 | 34,505,737 | 34.4 M to 34.5 M (+0.26 %) |
Nov 18 2015 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | P | 8.01 | 160,000 | 1,281,952 | 34,415,737 | 34.3 M to 34.4 M (+0.47 %) |
Oct 02 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.42 | 15,000 | 96,245 | 1,900,666 | 1.9 M to 1.9 M (+0.80 %) |
Oct 02 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.11 | 15,000 | 91,577 | 1,885,666 | 1.9 M to 1.9 M (+0.80 %) |
Sep 29 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.54 | 4,445 | 29,066 | 1,870,666 | 1.9 M to 1.9 M (+0.24 %) |
Sep 29 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 5.77 | 25,555 | 147,422 | 1,866,221 | 1.8 M to 1.9 M (+1.39 %) |
Sep 29 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.49 | 10,000 | 64,918 | 1,840,666 | 1.8 M to 1.8 M (+0.55 %) |
Sep 24 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 6.82 | 24,000 | 163,567 | 1,830,666 | 1.8 M to 1.8 M (+1.33 %) |
Aug 28 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Option Exercise | J | 0.00 | 1,344,186 | 0 | 23,655,814 | |
Aug 11 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 8.66 | 10,000 | 86,594 | 1,806,666 | 1.8 M to 1.8 M (+0.56 %) |
Aug 11 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 8.86 | 30,000 | 265,773 | 1,796,666 | 1.8 M to 1.8 M (+1.70 %) |
Aug 05 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 10.00 | 30,000 | 299,937 | 1,766,666 | 1.7 M to 1.8 M (+1.73 %) |
Aug 05 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 10.00 | 30,000 | 300,000 | 1,736,666 | 1.7 M to 1.7 M (+1.76 %) |
Aug 05 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 10.00 | 40,000 | 400,084 | 1,706,666 | 1.7 M to 1.7 M (+2.40 %) |
Aug 04 2015 | VTVT | vTv Therapeutics I ... | PERELMAN RONALD O | 10% Owner | Buy | P | 15.00 | 1,666,666 | 24,999,990 | 1,666,666 | 0 to 1.7 M |
Jun 12 2015 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 3,495 | 0 | 10,485 | |
Jun 12 2015 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | A | 0.00 | 9,937 | 0 | 9,937 | |
Jun 12 2015 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Buy | M | 0.00 | 3,495 | 0 | 54,044 | 50.5 K to 54 K (+6.91 %) |
Jun 08 2015 | SGMS | SCIENTIFIC GAMES C ... | PERELMAN RONALD O | Director | Option Exercise | M | 0.00 | 2,370 | 0 | 2,371 |